Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema

ClinOhio Research Services

Status

Completed

Conditions

Atopic Dermatitis Eczema

Treatments

Other: Arctiva

Study type

Interventional

Funder types

Industry

Identifiers

NCT05918237

ECZPROTOCOLOHIO115

Details and patient eligibility

About

Up to 30 participants with mild to moderate atopic dermatitis/eczema will be enrolled to apply study Investigational Product for 4 weeks.

Full description

This will be a 4-week single arm study. This study will be executed by one clinical research company in one research center accruing 30 subjects with mild to moderate Eczema/atopic dermatitis. Patients ages 18-75, will be enrolled. Subjects that are enrolled will be placed on Locus's Over The Counter cream "Arctiva" twice per day for 4 weeks.

Enrollment

30 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Male and Female;18-75 years of age
Have a clinical diagnosis of Mild to Moderate Eczema or Atopic Dermatitis
Signed and dated written informed consent in accordance with Good Clinical Practice (GCP) and local legislation prior to the start of any screening procedure

Exclusion criteria

Patients using topical corticosteroids steroidal creams and other agents within 7 days prior to first dose of trial Eczema treatment.
Use of systemic corticosteroids or other agents for atopic dermatitis within 4 weeks prior to first dose of trial treatment.
Active bacterial, viral, or fungal skin infections